CIK 0000711377 · Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 382367843
- Phone
- 5173729200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Stacey Jennifer Evans Chief Legal Officer | Grant or award | +39,349 | $9.53 | $375K | 39,349 |
| 2026-05-01 | Stacey Jennifer Evans Chief Legal Officer | Grant or award · Common Stock (Right to Buy) | +89,520 | 89,520 | ||
| 2026-02-17 | Nassif Mikheal CEO | Purchase | +23 | $10.94 | $252 | 704 |
| 2026-02-02 | Nassif Mikheal CEO | Purchase | +24 | $10.00 | $240 | 681 |
| 2026-01-26 | Nassif Mikheal CEO | Purchase | +25 | $9.86 | $246 | 657 |
| 2026-01-16 | Nassif Mikheal CEO | Purchase | +137 | $9.33 | $1K | 632 |
| 2026-01-07 | Ranalli Tamara A. Senior Vice President | Grant or award | +50,813 | $7.38 | $375K | 50,813 |
| 2026-01-07 | Ranalli Tamara A. Senior Vice President | Grant or award | +50,813 | $7.38 | $375K | 50,813 |
| 2026-01-07 | Ranalli Tamara A. Senior Vice President | Grant or award · Common Stock (Right to Buy) | +261,210 | 261,210 | ||
| 2026-01-07 | Ranalli Tamara A. Senior Vice President | Grant or award | +50,813 | $7.38 | $375K | 50,813 |
| 2026-01-07 | Ranalli Tamara A. Senior Vice President | Grant or award · Common Stock (Right to Buy) | +130,605 | 130,605 | ||
| 2025-12-01 | Naemura David H. Former CFO | Option exercise | +12,912 | $5.98 | $77K | 93,936 |
| 2025-12-01 | Naemura David H. Former CFO | Shares withheld for taxes | −3,548 | $5.98 | $21K | 90,388 |
| 2025-12-01 | Naemura David H. Former CFO | Option exercise · Restricted Stock Units | −12,912 | $5.98 | $77K | 0 |
| 2025-11-03 | Nassif Mikheal CEO | Purchase | +177 | $6.25 | $1K | 495 |
| 2025-11-03 | Riggsbee Richard Bryan CFO | Grant or award | +178,855 | $6.29 | $1.1M | 178,855 |
| 2025-11-03 | Riggsbee Richard Bryan CFO | Grant or award · Common Stock (Right to Buy) | +459,713 | 459,713 | ||
| 2025-10-27 | BOREL JAMES C Director | Option exercise | +1,777 | $6.19 | $11K | 96,347 |
| 2025-10-27 | BOREL JAMES C Director | Option exercise · Restricted Stock Units | −1,777 | $6.19 | $11K | 1,777 |
| 2025-10-27 | CAPELLO JEFFREY D Director | Option exercise | +1,777 | $6.19 | $11K | 32,502 |
Page 4 of 11 · 210 trades